Cargando…
miR-1205/DNAJB1 reverses docetaxel chemoresistance in human triple negative breast carcinoma cells via regulation of mutp53/TAp63 signaling: miR-1205/DNAJB1 reverses docetaxel chemoresistance in TNBC
Chemoresistance is the major cause of therapeutic failure in human triple negative breast carcinoma (TNBC). Docetaxel (DOC), a first-line therapeutic drug in TNBC treatment, is limited for long-term use due to the development of chemoresistance. Thus, overcoming chemoresistance of DOC remains an imp...
Autores principales: | Yin, Yongxiang, Zhang, Jinqiu, Ma, Tao, Chen, Daozhen, Lu, Daru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909320/ https://www.ncbi.nlm.nih.gov/pubmed/35130632 http://dx.doi.org/10.3724/abbs.2021006 |
Ejemplares similares
-
Circ‐UBAP2 functions as sponges of miR‐1205 and miR‐382 to promote glioma progression by modulating STC1 expression
por: Wang, Jianxin, et al.
Publicado: (2021) -
CircARVCF Contributes to Cisplatin Resistance in Gastric Cancer by Altering miR-1205 and FGFR1
por: Zhang, Ruirui, et al.
Publicado: (2021) -
Use of miR-145 and testicular nuclear receptor 4 inhibition to reduce chemoresistance to docetaxel in prostate cancer
por: Zhu, Jin, et al.
Publicado: (2021) -
Circ_0082182 promotes oncogenesis and metastasis of colorectal cancer in vitro and in vivo by sponging miR-411 and miR-1205 to activate the Wnt/β-catenin pathway
por: Liu, Ruijie, et al.
Publicado: (2021) -
Reciprocal regulation of miR-1205 and E2F1 modulates progression of laryngeal squamous cell carcinoma
por: Li, Pei, et al.
Publicado: (2019)